NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

Key Inclusion Criteria:

• Participant has a primary diagnosis of schizophrenia

• Participant is experiencing an acute exacerbation or relapse of symptoms andcurrently warrants hospitalization.

• Participants taking prohibited medications, including antipsychotics, mustdiscontinue before study participation

• Participant is willing and able to remain in an inpatient setting for the studyduration, follow instructions, and comply with the protocol requirements

Key Exclusion Criteria:

• Participant has known hypersensitivity to any component of the formulation ofNBI-1117568.

• Participant has an unstable or poorly controlled medical condition or chronicdisease

• Participant is considered by the investigator to be at imminent risk of suicide orinjury to self or others

• Participant has a diagnosis of moderate or severe substance use disorder (with theexception of nicotine or caffeine dependence) within 6 months prior to screening

• Participant has a positive alcohol test or drug screen for disallowed substances

• Participants have a history of poor or suspected poor compliance in clinicalresearch studies and/or in the investigator's opinion, the participant is notcapable of adhering to the protocol requirements.

Note: Other protocol-specified inclusion/exclusion criteria may apply.